Changes in intrahepatic gene expression profiles from chronic hepatitis to hepatocellular carcinoma in patients with hepatitis C virus infection

Hepatology Research

Volumn 38, Issue 7, 2008, Pages 673-682

  Furuta, Keiko ^a   Sato, Sayaka ^a   Yamauchi, Taeko ^a   Kakumu, Shinichi ^a,b  

^a AICHI MEDICAL UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b NONE   (Japan)

Author keywords

Chronic liver disease; HepatitisC virus; Intrahepatic gene expression; Pathogenesis

Indexed keywords

ACTIVATING TRANSCRIPTION FACTOR 3; ALPHA 2 MACROGLOBULIN; ANNEXIN; ANNEXIN A10; ARGINASE 1; C TYPE LECTIN LIKE RECEPTOR 2; CALGRANULIN B; COMPLEMENT COMPONENT C9; CXCL9 CHEMOKINE; CYSTEINE RICH PROTEIN 61; EARLY GROWTH RESPONSE FACTOR 1; FATTY ACID BINDING PROTEIN; HLA DQ ANTIGEN; HLA DQB2 ANTIGEN; IMMEDIATE EARLY PROTEIN; KRUPPEL LIKE FACTOR 6; LECTIN RECEPTOR; MACROPHAGE INFLAMMATORY PROTEIN 3BETA; PARATHYROID HORMONE RECEPTOR 1; PROTEIN FOS; RGS PROTEIN; RGS2 PROTEIN; SOMATOMEDIN B; SOMATOMEDIN BINDING PROTEIN; SOMATOMEDIN BINDING PROTEIN 1; STEROID 5ALPHA REDUCTASE 2; SUPPRESSOR OF CYTOKINE SIGNALING 3; TRANSCRIPTION FACTOR JUNB; TRISTETRAPROLIN;

ADULT; AGED; APOPTOSIS; ARTICLE; CELL CYCLE; CELL GROWTH; CELL PROLIFERATION; CHRONIC HEPATITIS; CLINICAL ARTICLE; DISEASE CLASSIFICATION; DISEASE COURSE; DOWN REGULATION; FEMALE; GENE CLUSTER; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE FUNCTION; GENE MAPPING; GENETIC ANALYSIS; GENETIC TRANSCRIPTION; HEPATITIS C; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNE RESPONSE; LIVER BIOPSY; LIVER CELL CARCINOMA; MALE; METABOLISM; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; UPREGULATION; VIRUS CARCINOGENESIS;

EID: 44649175827     PISSN: 13866346     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1872-034X.2008.00328.x     Document Type: Article

References (21)

1. Cerny A, Chisari FV. Pathogenesis of chronic hepatitis C: Immunological features of hepatic injury and viral persistence. Hepatology 1999; 30: 595-601.
2. Shiffman ML. Natural history and risk factors for progression of hepatitis C virus disease and development of hepatocellular carcinoma before liver transplantation. Liver Transpl 2003; 9 (Suppl.): S14-20.
3. Kiyosawa K, Sodeyama T, Tanaka E et al. Interrelationship between transfusion, non-A, non-B hepatitis and hepatocellular carcinoma: analysis by detection of antibody to hepatitis C virus. Hepatology 1990; 12: 671-5.
4. Shackel NA, McGuiness PH, Abbott CA, Gorrell MD, McCaughan GW. Insights into the pathobiology of hepatitis C virus-associated cirrhosis: analysis of intrahepatic differential gene expression. Am J Pathol 2002; 160: 641-54.
5. Nam SW, Park JY, Ramasamy A et al. Molecular changes from dysplastic nodule to hepatocellular carcinoma through gene expression profiling. Hepatology 2005; 42: 809-18.
6. Shirota Y, Kaneko S, Honda M, Kawai F, Kobayashi K. Identification of differentially expressed genes in hepatocellular carcinoma with cDNA microarrays. Hepatology 2001; 33: 832-40.
7. Okabe H, Satoh S, Kato T et al. Genome-wide analysis of gene expression in human hepatocellular carcinoma using cDNA microarray: Identification of genes involved in viral carcinogenesis and tumor progression. Cancer Res 2001; 61: 2129-37.
8. Iizuka N, Oka M, Yamada-Okabe H et al. Comparison of gene expression between hepatitis B virus- and hepatitis C virus-infected hepatocellular carcinoma by oligonucleotide microarray data on the basis of a supervised learning method. Cancer Res 2002; 62: 3939-44.
9. Chuma M, Sakamoto M, Yamazaki K et al. Expression profiling in multistage hepatocarcinogenesis: Identification of HSP70 as a molecular marker of early hepatocellular carcinoma. Hepatology 2003; 37: 198-207.
10. Neo SY, Leow CK, Vega VB et al. Identification of discriminators of hepatoma by gene expression profiling using a minimal dataset approach. Hepatology 2004; 39: 944-53.
11. Lee JS, Chu IS, Heo J et al. Classification and prediction of survival in hepatocellular carcinoma by gene expression profiling. Hepatology 2004; 40: 667-76.
12. Kurokawa Y, Matoba R, Takemasa I et al. Molecular-based prediction of early recurrence in hepatocellular carcinoma. J Hepatol 2004; 41: 284-91.
13. Honda M, Kaneko S, Kawai H, Shirota Y, Kobayashi K. Differential gene expression between chronic hepatitis B and C hepatic lesion. Gastroenterology 2001; 120: 955-66.
14. Otsuka M, Aizaki H, Kato N et al. Differential cellular gene expression induced by hepatitis B and C viruses. Biochem Biophs Res Commun 2003; 300: 443-7.
15. Lau DTY, Luxon BA, Xiao SY, Beard MR, Lemon SM. Intrahepatic gene expression profiles and alpha-smooth muscle actin patterns in hepatitis C virus induced fibrosis. Hepatology 2005; 42: 273-81.
16. Desmet VJ, Gerber M, Hoofnagle JH, Manns M, Scheuer PJ. Classification of chronic hepatitis: Diagnosis, grading and staging. Hepatology 1994; 19: 1513-20.
17. Moriya K, Yotsuyanagi H, Shintani Y et al. Hepatitis C virus core protein induces hepatic steatosis in transgenic mice. J Gen Virol 1997; 78: 1527-31.
18. Moriya K, Fujie H, Shintani Y et al. The core protein of hepatitis C virus induces hepatocellular carcinoma in transgenic mice. Nat Med 1998; 4: 1065-7.
19. Butterfield LA. Immunotherapeutic strategies for hepatocellular carcinoma. Gastroenterology 2004; 127: S232-S41.
20. Shackel NA, Gorrell MD, McCaughan GW. Gene array analysis and the liver. Hepatology 2002; 36: 1313-25.
21. Barton MC, Stivers DN. Microarray analysis of hepatic-regulated gene expression: Specific applications and non-specific problems. Hepatology 2002; 35: 727-9.